Skip to content

DOKTER LIESBETH STOKMAN

Active Private limited companyfounded 2022active for 4 yearsGoudenregenlaan 20, 2950 KapellenKBO/BCE: BE 0791.485.455

Lifetime

3 annual accounts with figures on one time axis
peak of €132,735 in 2024
€100,520▼ 24.3%
peak of €103,390 in 2024
€78,458▼ 24.1%
peak of €240,033 in 2025
€240,033▲ 48.6%
€12,014▲ 69.1%
Board1 name since 2022
1 director
Documentsfilings and deeds
20-03-2026133 days before the deadline
2025micro format
Gross margin from €132,735 to €100,520Equity from €161,576 to €240,033Debts from €7,106 to €12,014Investments €4,598Cash from €136,342 to €18,560

Key points

from the 2025 annual accounts

Equity

€240,033 ▲ 48.6%
€162,0002024€240,0002025

Equity rose in 2025 from €161,576 to €240,033.

Investments

€4,598 8.2 times depreciation
20242025

Green is investment, beige is depreciation. Machinery stands 155.5% higher than in 2024.

Position in the sector

95.2%

Higher solvency than 91% of companies in human health. The sector median is 63.1%, over 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as DOKTER LIESBETH STOKMAN has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for DOKTER LIESBETH STOKMAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 27-09-2022
  • 100 sharesdeed of 29-09-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0791485455
First establishment Goudenregenlaan 20, Kapellen
Incorporation Founding capital of €3,500, 100 shares · Founded by · appointed as mandate holder · published on 29-09-2022 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
DOKTER LIESBETH STOKMAN Kapellen €252,047 €100,520 95.2% -
Dr. Maarten Ruymaekers Antwerp €261,963 €102,566 93.6% -
Dr. Kato Van Gorp, huisarts Retie €257,714 €105,126 99.7% -
Dr. MC Dessel €249,803 €107,444 70.8% -
Dr. Chantal De Goignies, Huisarts Westerlo €245,222 €106,614 99.8% -
DR. GULDENTOPS LAURA - HUISARTS Lier €248,880 €88,395 87.3% -
Dr. Rumbaut Joris Boutersem €262,333 €103,189 89.3% 0

These companies have the same main activity as DOKTER LIESBETH STOKMAN: general medical practice (NACE 86210). They are comparable in size and age: total assets between €245,000 and €262,000, founded between 2022 and 2023.

Official details

Source: KBO
Status
Active since 27-09-2022Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.336.191.0552950 Kapellen, since 01-10-2022
Financial year end
31 December
Peppol
Reachable since 07-01-2025
Company details

Annual accounts 2025

≈ €180,000estimated
€252,047▲ 49.4%
Filing
Filed on 20-03-2026, 133 days before the end of the filing period
Financials

Insights on DOKTER LIESBETH STOKMAN

DOKTER LIESBETH STOKMAN files the micro format. That format states no turnover. The gross margin rose from €72,971 in 2023 to €100,520 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DOKTER LIESBETH STOKMAN

What is the company number of DOKTER LIESBETH STOKMAN?
The company number of DOKTER LIESBETH STOKMAN is 0791.485.455. The VAT number is the same number with BE in front: BE 0791.485.455.
Where is DOKTER LIESBETH STOKMAN based?
The registered office is at Goudenregenlaan 20, 2950 Kapellen.Company details
What does DOKTER LIESBETH STOKMAN do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTER LIESBETH STOKMAN?
DOKTER LIESBETH STOKMAN is a private limited company (BV).
When was DOKTER LIESBETH STOKMAN founded?
DOKTER LIESBETH STOKMAN was founded on 27-09-2022.
Is DOKTER LIESBETH STOKMAN still active?
Yes, DOKTER LIESBETH STOKMAN is an active enterprise in the KBO register.
What is the turnover of DOKTER LIESBETH STOKMAN?
The turnover in financial year 2025 is about €180,000. This figure is estimated from the gross margin of €100,520 and 30 comparable companies (NACE 86210). It probably lies between €150,000 and €230,000.Financials
Is DOKTER LIESBETH STOKMAN profitable?
In financial year 2025, DOKTER LIESBETH STOKMAN made a profit of €78,458.
Where can I find the annual accounts of DOKTER LIESBETH STOKMAN?
DOKTER LIESBETH STOKMAN filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER LIESBETH STOKMAN due?
DOKTER LIESBETH STOKMAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.